A glimmer of hope sparked following the first results from human trials of a vaccine against the novel Coronavirus, after US firm’s study saw positive results in a group of eight volunteers.
The hopeful results showed that each one of the volunteers produced an antibody response on a par with that seen in people who have had the disease.
Even though the results from this first-stage trial doesn’t necessarily mean that the treatment will work, it is a sign of a breakthrough in a battle that shall hopefully come to an end soon.
This US study is run by the National Institutes of Allergy and Infectious Diseases, it showed that all eight volunteers made neutralizing antibodies which were tested in human cells in the lab and stopped the virus from replicating.
The higher the vaccine dose, the more antibodies the volunteer produced.
This isn’t the first trial for a vaccine that should give you hope, as the US National Institutes of Health Moderna is also planning to start a mid-stage study soon and then begin a late-stage trial in July.
The company also hopes to have the vaccine ready by fall for emergency cases, a timeline with no precedent in the history of vaccine development.
Until we hear more from these trials, we have got to stay hopeful and most importantly stay home for our own safety as well as others’.